PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-10.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.18B
AUM Growth
+$3.18B
(-36%)
Cap. Flow
-$557M
Cap. Flow
% of AUM
-17.5%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
144
New
7
Increased
15
Reduced
49
Closed
31
Top Buys
| 1 |
Amylyx Pharmaceuticals
AMLX
|
$39.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.6M |
| 3 |
Lyra Therapeutics
LYRA
|
$33.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.6M |
| 5 |
Eli Lilly
LLY
|
$32.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$143M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$52.5M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$34.5M |
| 4 |
Penumbra
PEN
|
$31.9M |
| 5 |
Travere Therapeutics
TVTX
|
$30.9M |
Sector Composition
| 1 | Healthcare | 84.05% |
| 2 | Consumer Discretionary | 0.04% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
51
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $13.5M | 0.42% |
3,536,274
-118,933
| -3% | -$454K |
|
52
Treace Medical Concepts
TMCI
$458M
| $13.5M | 0.42% |
941,192
-30,000
| -3% | -$430K |
|
|
VRNA
53
Verona Pharma
VRNA
$9.18B
| $12.2M | 0.38% |
2,915,146
-129,157
| -4% | -$541K |
|
54
Viridian Therapeutics
VRDN
$1.59B
| $11.2M | 0.35% |
971,832
-451,221
| -32% | -$5.22M |
|
|
CCXI
55
DELISTED
ChemoCentryx, Inc.
CCXI
| $10.9M | 0.34% |
441,680
-1,213,399
| -73% | -$30.1M |
|
|
CMAX
56
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $10.9M | 0.34% |
3,000,000
-186,663
| -6% | -$678K |
|
|
LABP
57
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $10.8M | 0.34% |
14,869,915
| – | – |
|
58
Day One Biopharmaceuticals
DAWN
$766M
| $9.95M | 0.31% |
556,047
| – | – |
|
59
Verrica Pharmaceuticals
VRCA
$49.4M
| $9.68M | 0.3% |
5,038,983
+1,428,571
| +40% | +$2.74M |
|
60
Leap Therapeutics
LPTX
$12M
| $9.14M | 0.29% |
7,951,448
| – | – |
|
|
CNCE
61
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $9.05M | 0.28% |
2,150,641
| – | – |
|
|
ISO
62
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $8.85M | 0.28% |
4,095,498
| – | – |
|
|
KRON
63
DELISTED
Kronos Bio
KRON
| $8.81M | 0.28% |
2,421,142
| – | – |
|
64
HilleVax
HLVX
$105M
| $8.36M | 0.26% |
+764,907
| New | +$8.36M |
|
65
Solid Biosciences
SLDB
$448M
| $8.26M | 0.26% |
13,412,552
| – | – |
|
66
Privia Health
PRVA
$2.84B
| $7.96M | 0.25% |
273,423
+60,000
| +28% | +$1.75M |
|
|
RVNC
67
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.91M | 0.25% |
572,514
+435,000
| +316% | +$6.01M |
|
|
MORF
68
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.88M | 0.25% |
363,197
-404,130
| -53% | -$8.77M |
|
|
PNT
69
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $7.31M | 0.23% |
1,073,995
-120,000
| -10% | -$817K |
|
|
SLGC
70
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $6.78M | 0.21% |
1,500,000
| – | – |
|
71
Health Catalyst
HCAT
$228M
| $6.74M | 0.21% |
465,162
-28,500
| -6% | -$413K |
|
72
GeneDx Holdings
WGS
$3.65B
| $6.3M | 0.2% |
5,000,000
+2,500,000
| +100% | +$3.15M |
|
|
ICVX
73
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $5.98M | 0.19% |
1,042,850
-336,287
| -24% | -$1.93M |
|
74
C4 Therapeutics
CCCC
$182M
| $5.78M | 0.18% |
766,231
-1,316,492
| -63% | -$9.93M |
|
75
Nuvation Bio
NUVB
$1.08B
| $5.73M | 0.18% |
1,769,701
| – | – |
|